研究报告 |
|
|
|
|
前肽缺失体vWF改善FVIII基因断裂转移 细胞的重链和活性分泌 |
朱甫祥, 刘泽隆, 缪静, 屈慧鸽, 迟晓艳 |
鲁东大学生命科学学院 烟台 264025 |
|
Propeptide-deleted von Willebrand Factor Improves Heavy Chain Secretion and Bioactivity by Split FVIII Gene Co-transfected Cells |
ZHU Fu-xiang, LIU Ze-long, MIAO Jing, QU Hui-ge, CHI Xiao-yan |
Life Science College of Ludong University, Yantai 264025, China |
引用本文:
朱甫祥, 刘泽隆, 缪静, 屈慧鸽, 迟晓艳. 前肽缺失体vWF改善FVIII基因断裂转移 细胞的重链和活性分泌[J]. 中国生物工程杂志, 2012, 32(07): 20-25.
ZHU Fu-xiang, LIU Ze-long, MIAO Jing, QU Hui-ge, CHI Xiao-yan. Propeptide-deleted von Willebrand Factor Improves Heavy Chain Secretion and Bioactivity by Split FVIII Gene Co-transfected Cells. China Biotechnology, 2012, 32(07): 20-25.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I07/20
|
[1] Arruda V R, Stedman H H, Haurigot V, et al. Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B. Blood, 2010, 115(23): 4678-4688. [2] Niemeyer G P, Herzog R W, Mount J, et al. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood, 2009, 113(4): 797-806. [3] Mah C, Sarkar R, Zolotukhin I, et al. Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice. Hum Gene Ther, 2003, 14(2): 143-152. [4] Chen L X, Lu H, Wang J H, et al. Enhanced factor VIII heavy chain for gene therapy of hemophilia A. Mol Ther, 2009, 17(3): 417-424. [5] Scallan C D, Liu T, Parker A E, et al. Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII. Blood, 2003, 102(12): 3919-3926. [6] Burton M, Nakai H, Colosi P, et al. Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein. Proc Natl Acad Sci USA, 1999, 96(22): 12725-12730. [7] Zhang K, Shen X, Wu J, et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell, 2006, 124(3): 587-599. [8] De Meyer S F, Deckmyn H, Vanhoorelbeke K. von Willebrand factor to the rescue. Blood, 2009, 113(21): 5049-5057. [9] Wise R J, Dorner A J, Krane M, et al. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem, 1991, 266(32): 21948-21955. [10] 朱甫祥,杨树德,刘泽隆,等. vWF-ΔPro改善基于蛋白质剪接的双载体BDD-FVIII基因转移. 中国生物化学与分子生物学报, 2010; 26(8): 720-726. Zhu F X, Yang S D, Liu Z L, et al. vWF-ΔPro improves protein splicing-based dual vector transfer of B-domain-deleted FVIII gene.Chin J Biochem Mol Biol, 2010, 26(8): 720-726. [11] Zhu F X, Liu Z L, Chi X Y, et al. Protein trans-splicing based dual-vector delivery of the coagulation factor VIII gene. Sci China Life Sci, 2010, 53(6): 683-689. [12] Lankhof H, van Hoeij M, Schiphorst M E, et al. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost, 1996, 75(6): 950-958. [13] Chen L X, Zhu F X, Li J, et al. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther, 2007, 15(10): 1856-1862. [14] Sarkar R, Tetreault R, Gao G, et al. Total correction of hemophiliaAmice with canine FVIII using anAAV 8 serotype. Blood, 2004, 103(4): 1253-1260. [15] Swaroop M, Moussalli M, Pipe S W, et al. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J Biol Chem, 1997, 272(39): 24121-24124. [16] Dorner A J, Wasley L C, Kaufman R J. Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J Biol Chem, 1989, 264(34): 20602-20607. [17] Kaufman R J, Wasley L C, Dorner A J. Synthesis, processing, and secretion of recombinant human factor VI11 expressed in mammalian cell. J Biol Chem, 1988, 263(13): 6352-6362. [18] Chen L X, Lu H, Wang J H, et al. Enhanced factor VIII heavy chain for gene therapy of hemophilia A. Mol Ther, 2009, 17(3): 417-424. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|